Weight-loss start-up emerges from stealth

Unlike popular GLP-1 agonists, Helicore’s lead asset targets GIP receptors

Feb 9, 2025 - 22:14
 0
Weight-loss start-up emerges from stealth
Unlike popular GLP-1 agonists, Helicore’s lead asset targets GIP receptors